52 devices · GMDN 57238
Glial fibrillary acidic protein (GFAP) IVD antibody devices are laboratory tests designed to detect the presence of GFAP in patient samples, such as blood or cerebrospinal fluid. Clinically, these tests help diagnose or monitor conditions like brain injuries, neurodegenerative diseases, or tumors by identifying markers associated with glial cell damage or activity.
These devices are typically regulated as in vitro diagnostics (IVDs) and may vary in supply formats, including kits, reagents, or automated systems. Classification and availability depend on the jurisdiction, with some requiring specific laboratory settings or professional use. Always verify local regulatory requirements before use.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.